Benitec BiopharmaBNTC
13F holders, Q3 2024 (September 30)25holders +7
7new positions
0sold out
1famous investor
$9.24avg. 13F price*
At the end of Q3 2024, 25 institutions reported holding Benitec Biopharma Inc. (BNTC) in their 13F filings, up 7 from Q2 2024. 7 opened new positions and 0 sold out. The largest holders were Montanova Capital, LLC ($81.1M), Franklin Resources Inc. ($8.1M) and Janus Henderson Group PLC ($8.0M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Benitec Biopharma Inc.
- CUSIP
- 08205P209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $7.2M |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 8,020,129 shares bought and 34,799 shares sold, net +7,985,330 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 25 holders
| Montanova Capital, LLC | 2.91% | Add +422.0% | 8,829,053 | $81.1M |
| Franklin Resources Inc. | 0.00% | No change | 796,644 | $8.1M |
| Janus Henderson Group PLC | 0.00% | Reduce -2.7% | 876,523 | $8.0M |
| Adage Capital Partners Gp, L.L.C. | 0.01% | No change | 841,395 | $7.7M |
| Nantahala Capital Management, LLC | 0.65% | Reduce -0.4% | 838,095 | $7.7M |
| AWM Investment Company, Inc. | 0.70% | New | 625,000 | $5.7M |
| Schonfeld Strategic Advisors LLC | 0.02% | Add +4.8% | 272,817 | $2.5M |
| Vanguard Group Inc. | 0.00% | Reduce -0.9% | 213,067 | $2.0M |
| Simplify Asset Management Inc. | 0.07% | Add +127.5% | 116,535 | $1.1M |
| Geode Capital Management, LLC | 0.00% | Add +31.3% | 83,987 | $772K |
| Armistice Capital, LLC | 0.01% | New | 60,000 | $551K |
| Lion Point Capital, LP | 1.44% | New | 39,000 | $358K |
| Acuta Capital Partners, LLC | 0.22% | New | 29,800 | $274K |
| BlackRock, Inc. | 0.00% | — | 28,238 | $260K |
| Northern Trust Corp. | 0.00% | Reduce -0.6% | 24,775 | $228K |
| Ameriprise Financial Inc. | 0.00% | New | 14,879 | $137K |
| Citadel Advisors | 0.00% | New | 14,244 | $131K |
| GAMMA Investing LLC | 0.01% | Add +20.3% | 6,540 | $60K |
| UBS Group AG | 0.00% | Reduce -5.3% | 1,924 | $18K |
| Morgan Stanley | 0.00% | Reduce -76.4% | 1,324 | $12K |
| NewEdge Advisors, LLC | 0.00% | New | 610 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -74.2% | 230 | $2K |
| Rhumbline Advisers | 0.00% | No change | 186 | $2K |
| Group One Trading LLC | 0.00% | No change | 89 | $818 |
| Bank of America Corp. | 0.00% | Reduce -11.7% | 68 | $625 |
"% of holder's portfolio" is BNTC's weight in each manager's 13F, not the share of Benitec Biopharma Inc. the manager owns.